Previsioni di mercato dei reagenti e delle apparecchiature per trasfezione per il Nord America fino al 2030 - Analisi regionale - per prodotto (reagenti e strumenti), metodo (metodi virali, metodi non virali e metodi ibridi), applicazione (ricerca biomedica, produzione di proteine e somministrazione terapeutica), e Utente finale (Università e Istituti di ricerca e Aziende farmaceutiche e biotecnologiche)
Le iniziative strategiche delle aziende alimentano il mercato dei reagenti e delle apparecchiature per trasfezione del Nord America
Le società che operano nel mercato dei reagenti e delle apparecchiature per trasfezione del Nord America focalizzazione del mercato su sviluppi strategici come collaborazioni, espansioni, accordi, partnership e lancio di nuovi prodotti, che li aiutano a migliorare le vendite, espandere la portata geografica e migliorare le loro capacità di soddisfare una base di clienti più ampia di quella esistente. Questi sviluppi contribuiscono in una certa misura anche all’introduzione di nuove tendenze nel mercato. Di seguito sono menzionati alcuni degli sviluppi degni di nota nel mercato dei reagenti e delle apparecchiature per trasfezione del Nord America.
Nell\'aprile 2023, Thermo Fisher Scientific ha lanciato il sistema di elettroporazione Invitrogen Neon NxT che facilita la trasfezione, anche con i tipi cellulari più difficili, consentendo elevata efficienza, recupero cellulare e riproducibilità. Gli elettrodi Neon NxT sono posizionati in modo ottimale per fornire un\'area superficiale minima e creare un campo elettrico più uniforme e mantenere condizioni fisiologiche adeguate durante la trasfezione, consentendo così che la modifica desiderata avvenga in più cellule e riducendo il numero di cellule perse durante il processo. Il nuovo sistema presenta inoltre un circuito di feedback migliorato e miglioramenti ergonomici per una maggiore facilità d\'uso. Nell\'agosto 2021, Mirus Bio ha lanciato la linea di prodotti TransIT VirusGEN GMP, che fornisce reagenti di trasfezione e potenziatori per supportare la produzione di vettori virali per lo sviluppo di terapie geniche. Il reagente di trasfezione TransIT VirusGEN GMP è stato sviluppato per migliorare la consegna del DNA del vaccino di trasferimento alle cellule HEK 293 in sospensione e aderenti per rendere più efficiente la produzione di vettori AAV e LV ricombinanti. Nel luglio 2020, Polyplus-transfection SA ha lanciato il primo test residuo conforme alle GMP per il suo portafoglio di prodotti PEIpro di reagenti di trasfezione progettati per supportare lo sviluppo del processo preclinico, clinico e commerciale di produzione di lentivirus e virus adeno-associati (AAV) per terapie cellulari e geniche. Inoltre, Polyplus-transfection ha anche lanciato il doppio approvvigionamento per il suo prodotto PEIpro-GMP per terapie cellulari e geniche in fase avanzata e di commercializzazione. Pertanto, l\'introduzione di prodotti come reagenti e sistemi di trasfezione; lo sviluppo di prodotti innovativi mirati a vari problemi sanitari per creare prodotti nuovi o migliorati; e l’avvio di nuove attività per rimanere competitivi sul mercato, tutto, attraverso collaborazioni e partenariati, può aiutare ad accelerare lo sviluppo di nuove piattaforme per reagenti e apparecchiature di trasfezione.
Panoramica del mercato dei reagenti e delle apparecchiature per trasfezione in Nord America
Le terapie cellulari e geniche (CGT) sono prescritte per trattare pazienti affetti da malattie gravi e rare con esigenze terapeutiche non soddisfatte. La produzione di CGT è un processo estremamente complesso, in cui l’insufficienza di infrastrutture e competenze costituisce un importante fattore limitante. Anche le sfide legate alla logistica associate agli intermedi e al prodotto finale limitano la capacità di produzione di CGT delle aziende. Il processo di produzione della CGT prevede l\'estrazione di cellule autologhe tramite \"aferesi\", l\'invio a laboratori specializzati e il reinvio alle cliniche per la somministrazione ai pazienti, il tutto deve essere eseguito con un rigoroso controllo di qualità. La Food and Drug Administration (FDA) statunitense ha approvato finora solo 7 farmaci CGT e la pipeline di nuovi prodotti ha raggiunto circa 1.200 terapie sperimentali. La metà di questi sono in studi clinici di Fase 2. Con queste prospettive, si stima che le vendite annuali di terapie cellulari e terapie geniche cresceranno rispettivamente del 15% e del 30% circa, come indicato nel Chemical & Engineering News Report 2023.
Molti produttori si rivolgono a organizzazioni di produzione per lo sviluppo a contratto (CDMO) come Labcorp, Lonza e Catalent per superare le barriere associate alla produzione e alla commercializzazione dei loro prodotti CGT. Lonza ha investito circa 9,2 milioni di dollari per rafforzare le proprie capacità di produzione di terapie cellulari e geniche. Tali iniziative dei CDMO stanno contribuendo alla crescita del mercato dei reagenti e delle apparecchiature per trasfezione negli Stati Uniti.
Inoltre, nel febbraio 2022, François-Philippe Champagne, ministro dell\'Innovazione, della Scienza e dell\'Industria, ha annunciato il finanziamento di 45 milioni di dollari al governo del Canada attraverso la Canada Foundation for Innovation (CFI) per garantire che i gruppi di ricerca dispongano di laboratori e infrastrutture adeguati e abbiano accesso ai dipartimenti tecnologici per portare avanti ricerche di livello mondiale. Il Canadian Institutes of Health Research (CIHR) ha annunciato una partnership con il Quebec Consortium for Drug Discovery (CQDM) per un nuovo programma di finanziamento collaborativo sulla medicina personalizzata per accelerare la scoperta e lo sviluppo di farmaci.
Entrate e previsioni del mercato dei reagenti e delle apparecchiature per trasfezione del Nord America fino al 2030 (milioni di dollari)
Segmentazione del mercato dei reagenti e delle apparecchiature per trasfezione del Nord America
Reagenti e delle apparecchiature per la trasfezione del Nord America il mercato è segmentato in base a prodotto, metodo, applicazione, utente finale e paese.
In base al prodotto, il mercato dei reagenti e delle apparecchiature per trasfezione del Nord America è suddiviso in reagenti e strumenti. Il segmento dei reagenti ha detenuto una quota maggiore nel 2022.
In termini di metodo, il mercato dei reagenti e delle apparecchiature per trasfezione del Nord America è segmentato in metodi virali, metodi non virali e metodi ibridi. Il segmento dei metodi non virali ha detenuto la quota maggiore nel 2022. Il segmento virale è suddiviso in retrovirus, adenovirus, virus adenoassociato e virus dell\'herpes. Il segmento non virale è biforcato in metodo fisico/meccanico e metodo chimico. Inoltre, il segmento del metodo fisico/meccanico è suddiviso in elettroporazione, microiniezione, metodo biolistico, metodo laser, magnetofezione e sonoporazione. Inoltre, il segmento dei metodi chimici è suddiviso in sottocategorie a base liposomiale/ad alto contenuto lipidico e non liposomiale/ad alto contenuto lipidico.
Per applicazione, il mercato dei reagenti e delle apparecchiature per trasfezione del Nord America è segmentato nella ricerca biomedica, nella produzione di proteine e nella somministrazione terapeutica. Il segmento della ricerca biomedica ha detenuto la quota maggiore nel 2022.
In base all\'utente finale, il mercato dei reagenti e delle apparecchiature per trasfezione del Nord America è biforcato in accademici e istituti di ricerca e aziende farmaceutiche e biotecnologiche. Il segmento degli accademici e degli istituti di ricerca ha detenuto una quota maggiore nel 2022.
In base al paese, il mercato dei reagenti e delle apparecchiature per trasfezione del Nord America è classificato negli Stati Uniti, Canada e Messico. Gli Stati Uniti hanno dominato il mercato dei reagenti e delle apparecchiature per trasfezione del Nord America nel 2022.
Thermo Fisher Scientific Inc, Promega Corp, F. Hoffmann-La Roche Ltd, Bio-Rad Laboratories Inc, Mirus Bio LLC, QIAGEN NV, Merck KGaA, Lonza Group AG, MaxCyte Inc e Polyplus-Transfection SA sono alcune delle aziende leader che operano nel mercato dei reagenti e delle apparecchiature per trasfezione del Nord America.
TABLE OF CONTENTS
1. Introduction
1.1 The Insight Partners Research Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Insights
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. North America Transfection Reagents and Equipment Market - Key Market Dynamics
4.1 North America Transfection Reagents and Equipment Market - Key Market Dynamics
4.2 Market Drivers
4.2.1 Increasing Popularity of Cell and Gene Therapy
4.2.2 Growing Economic Burden of Cancer
4.3 Market Restraints
4.3.1 High Cost of Instruments and Consumables
4.4 Market Opportunities
4.4.1 Ramping Up Small-Scale Processes to Large-Scale Processes
4.5 Future Trends
4.5.1 Strategic Initiatives by Companies
4.6 Impact of Drivers and Restraints:
5. Transfection Reagents and Equipment Market - North America Market Analysis
5.1 North America Transfection Reagents and Equipment Market Revenue (US$ Million), 2022-2030
5.2 North America Transfection Reagents and Equipment Market Forecast Analysis
6. North America Transfection Reagents and Equipment Market Analysis - by Product
6.1 Reagents
6.1.1 Overview
6.1.2 Reagents: North America Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
6.2 Equipment
6.2.1 Overview
6.2.2 Equipment: North America Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
7. North America Transfection Reagents and Equipment Market Analysis - by Modality
7.1 Viral
7.1.1 Overview
7.1.2 Viral: North America Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
7.1.2.1 Retrovirus: North America Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
7.1.2.2 Adenovirus: North America Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
7.1.2.3 Adeno-Associated Virus: North America Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
7.1.2.4 Herpes Virus: North America Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
7.2 Non-Viral
7.2.1 Overview
7.2.2 Non-Viral: North America Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
7.2.2.1 Physical/Mechanical Method: North America Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
7.2.2.1.1 Electroporation: North America Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
7.2.2.1.2 Microinjection: North America Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
7.2.2.1.3 Biolistic Method: North America Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
7.2.2.1.4 Laser Method: North America Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
7.2.2.1.5 Magnetofection: North America Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
7.2.2.1.6 Sonoporation: North America Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
7.2.2.2 Chemical Method: North America Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
7.2.2.2.1 Liposomal Based/High Lipid: North America Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
7.2.2.2.2 Non-Liposomal Based/High Lipid: North America Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
7.3 Hybrid
7.3.1 Overview
7.3.2 Hybrid: North America Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
8. North America Transfection Reagents and Equipment Market Analysis - by Application
8.1 Biomedical Research
8.1.1 Overview
8.1.2 Biomedical Research: North America Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
8.2 Protein Production
8.2.1 Overview
8.2.2 Protein Production: North America Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
8.3 Therapeutic Delivery
8.3.1 Overview
8.3.2 Therapeutic Delivery: North America Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
9. North America Transfection Reagents and Equipment Market Analysis - by End Users
9.1 Academic and Research Institutes
9.1.1 Overview
9.1.2 Academic and Research Institutes: North America Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
9.2 Pharmaceutical and Biotechnological Companies
9.2.1 Overview
9.2.2 Pharmaceutical and Biotechnological Companies: North America Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
10. North America Transfection Reagents and Equipment Market -Country Analysis
10.1 North America: Transfection Reagents and Equipment Market - Revenue and Forecast Analysis - by Country
10.1.1 North America: Transfection Reagents and Equipment Market - Revenue and Forecast Analysis - by Country
10.1.1.1 United States: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
10.1.1.1.1 United States: Transfection Reagents and Equipment Market Breakdown, by Product
10.1.1.1.2 United States: Transfection Reagents and Equipment Market Breakdown, by Modality
10.1.1.1.2.1 United States: Transfection Reagents and Equipment Market Breakdown, by Viral
10.1.1.1.2.2 United States: Transfection Reagents and Equipment Market Breakdown, by Non-Viral
10.1.1.1.2.2.1 United States: Transfection Reagents and Equipment Market Breakdown, by Physical/mechanical Method
10.1.1.1.2.2.2 United States: Transfection Reagents and Equipment Market Breakdown, by Chemical Method
10.1.1.1.3 United States: Transfection Reagents and Equipment Market Breakdown, by Application
10.1.1.1.4 United States: Transfection Reagents and Equipment Market Breakdown, by End Users
10.1.1.2 Canada: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
10.1.1.2.1 Canada: Transfection Reagents and Equipment Market Breakdown, by Product
10.1.1.2.2 Canada: Transfection Reagents and Equipment Market Breakdown, by Modality
10.1.1.2.2.1 Canada: Transfection Reagents and Equipment Market Breakdown, by Viral
10.1.1.2.2.2 Canada: Transfection Reagents and Equipment Market Breakdown, by Non-Viral
10.1.1.2.2.2.1 Canada: Transfection Reagents and Equipment Market Breakdown, by Physical/mechanical Method
10.1.1.2.2.2.2 Canada: Transfection Reagents and Equipment Market Breakdown, by Chemical Method
10.1.1.2.3 Canada: Transfection Reagents and Equipment Market Breakdown, by Application
10.1.1.2.4 Canada: Transfection Reagents and Equipment Market Breakdown, by End Users
10.1.1.3 Mexico: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
10.1.1.3.1 Mexico: Transfection Reagents and Equipment Market Breakdown, by Product
10.1.1.3.2 Mexico: Transfection Reagents and Equipment Market Breakdown, by Modality
10.1.1.3.2.1 Mexico: Transfection Reagents and Equipment Market Breakdown, by Viral
10.1.1.3.2.2 Mexico: Transfection Reagents and Equipment Market Breakdown, by Non-Viral
10.1.1.3.2.2.1 Mexico: Transfection Reagents and Equipment Market Breakdown, by Physical/mechanical Method
10.1.1.3.2.2.2 Mexico: Transfection Reagents and Equipment Market Breakdown, by Chemical Method
10.1.1.3.3 Mexico: Transfection Reagents and Equipment Market Breakdown, by Application
10.1.1.3.4 Mexico: Transfection Reagents and Equipment Market Breakdown, by End Users
11. Transfection Reagents and Equipment Market -Industry Landscape
11.1 Overview
11.2 Growth Strategies in The Transfection Reagents and Equipment Market, 2020-2023
11.3 Inorganic Growth Strategies
11.3.1 Overview
11.4 Organic Growth Strategies
11.4.1 Overview
12. Company Profiles
12.1 Thermo Fisher Scientific Inc
12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Products and Services
12.1.4 Financial Overview
12.1.5 SWOT Analysis
12.1.6 Key Developments
12.2 Promega Corp
12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Products and Services
12.2.4 Financial Overview
12.2.5 SWOT Analysis
12.2.6 Key Developments
12.3 F. Hoffmann-La Roche Ltd
12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Products and Services
12.3.4 Financial Overview
12.3.5 SWOT Analysis
12.3.6 Key Developments
12.4 Bio-Rad Laboratories Inc
12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Products and Services
12.4.4 Financial Overview
12.4.5 SWOT Analysis
12.4.6 Key Developments
12.5 Mirus Bio LLC
12.5.1 Key Facts
12.5.2 Business Description
12.5.3 Products and Services
12.5.4 Financial Overview
12.5.5 SWOT Analysis
12.5.6 Key Developments
12.6 QIAGEN NV
12.6.1 Key Facts
12.6.2 Business Description
12.6.3 Products and Services
12.6.4 Financial Overview
12.6.5 SWOT Analysis
12.6.6 Key Developments
12.7 Merck KGaA
12.7.1 Key Facts
12.7.2 Business Description
12.7.3 Products and Services
12.7.4 Financial Overview
12.7.5 SWOT Analysis
12.7.6 Key Developments
12.8 Lonza Group AG
12.8.1 Key Facts
12.8.2 Business Description
12.8.3 Products and Services
12.8.4 Financial Overview
12.8.5 SWOT Analysis
12.8.6 Key Developments
12.9 MaxCyte Inc
12.9.1 Key Facts
12.9.2 Business Description
12.9.3 Products and Services
12.9.4 Financial Overview
12.9.5 SWOT Analysis
12.9.6 Key Developments
12.10 Polyplus-Transfection SA
12.10.1 Key Facts
12.10.2 Business Description
12.10.3 Products and Services
12.10.4 Financial Overview
12.10.5 SWOT Analysis
12.10.6 Key Developments
13. Appendix
13.1 About Us
List of Tables
Table 1. North America Transfection Reagents and Equipment Market Segmentation
Table 2. North America Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
Table 3. North America Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million) - by Product
Table 4. North America Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million) - by Modality
Table 5. North America Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million) - by Viral
Table 6. North America Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million) - by Non-Viral
Table 7. North America Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million) - by Physical/mechanical Method
Table 8. North America Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million) - by Chemical Method
Table 9. North America Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million) - by Application
Table 10. North America Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million) - by End Users
Table 11. North America: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Country
Table 12. United States: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Product
Table 13. United States: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Modality
Table 14. United States: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Viral
Table 15. United States: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Non-Viral
Table 16. United States: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Physical/mechanical Method
Table 17. United States: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Chemical Method
Table 18. United States: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Application
Table 19. United States: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by End Users
Table 20. Canada: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Product
Table 21. Canada: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Modality
Table 22. Canada: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Viral
Table 23. Canada: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Non-Viral
Table 24. Canada: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Physical/mechanical Method
Table 25. Canada: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Chemical Method
Table 26. Canada: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Application
Table 27. Canada: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by End Users
Table 28. Mexico: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Product
Table 29. Mexico: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Modality
Table 30. Mexico: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Viral
Table 31. Mexico: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Non-Viral
Table 32. Mexico: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Physical/mechanical Method
Table 33. Mexico: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Chemical Method
Table 34. Mexico: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Application
Table 35. Mexico: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by End Users
Table 36. Recent Inorganic Growth Strategies in the Transfection Reagents and Equipment Market
Table 37. Recent Organic Growth Strategies in The Transfection Reagents and Equipment Market
List of Figures
Figure 1. North America Transfection Reagents and Equipment Market Segmentation, by Country
Figure 2. Impact Analysis of Drivers and Restraints
Figure 3. North America Transfection Reagents and Equipment Market Revenue (US$ Million), 2022-2030
Figure 4. North America Transfection Reagents and Equipment Market Share (%) - by Product (2022 and 2030)
Figure 5. Reagents: North America Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 6. Equipment: North America Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 7. North America Transfection Reagents and Equipment Market Share (%) - by Modality (2022 and 2030)
Figure 8. Viral: North America Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 9. Retrovirus: North America Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 10. Adenovirus: North America Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 11. Adeno-Associated Virus: North America Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 12. Herpes Virus: North America Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 13. Non-Viral: North America Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 14. Physical/Mechanical: North America Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 15. Electroporation: North America Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 16. Microinjection: North America Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 17. Biolistic Method: North America Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 18. Laser Method: North America Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 19. Magnetofection: North America Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 20. Sonoporation: North America Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 21. Chemical Method: North America Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 22. Liposomal Based/High Lipid: North America Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 23. Non-Liposomal Based/High Lipid: North America Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 24. Hybrid: North America Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 25. North America Transfection Reagents and Equipment Market Share (%) - by Application (2022 and 2030)
Figure 26. Biomedical Research: North America Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 27. Protein Production: North America Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 28. Therapeutic Delivery: North America Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 29. North America Transfection Reagents and Equipment Market Share (%) - by End Users (2022 and 2030)
Figure 30. Academic and Research Institutes: North America Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 31. Pharmaceutical and Biotechnological Companies: North America Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 32. North America: Transfection Reagents and Equipment Market- Revenue by Key Countries 2022 (US$ Million)
Figure 33. North America: Transfection Reagents and Equipment Market Breakdown, by Key Countries, 2022 and 2030 (%)
Figure 34. United States: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million)
Figure 35. Canada: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million)
Figure 36. Mexico: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million)
Figure 37. Growth Strategies in The Transfection Reagents and Equipment Market, 2020-2023
1. Thermo Fisher Scientific Inc
2. Promega Corp
3. F. Hoffmann-La Roche Ltd
4. Bio-Rad Laboratories Inc
5. Mirus Bio LLC
6. QIAGEN NV
7. Merck KGaA
8. Lonza Group AG
9. MaxCyte Inc
10. Polyplus-Transfection SA
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the North America transfection reagents and equipment market.
- Highlights key business priorities in order to assist companies to realign their business strategies.
- The key findings and recommendations highlight crucial progressive industry trends in North America transfection reagents and equipment market, thereby allowing players across the value chain to develop effective long-term strategies.
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
- Scrutinize in-depth North America market trends and outlook coupled with the factors driving the market, as well as those hindering it.
- Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing, and distribution.